State Street’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18M | Buy |
318,771
+308,241
| +2,927% | +$3.08M | ﹤0.01% | 3131 |
|
|
2025
Q1 | $925K | Sell |
10,530
-195
| -2% | -$17.1K | ﹤0.01% | 3445 |
|
|
2024
Q4 | $995K | Buy |
10,725
+226
| +2% | +$21K | ﹤0.01% | 3491 |
|
|
2024
Q3 | $768K | Buy |
10,499
+751
| +8% | +$54.9K | ﹤0.01% | 3523 |
|
|
2024
Q2 | $566K | Buy |
9,748
+3,177
| +48% | +$185K | ﹤0.01% | 3552 |
|
|
2024
Q1 | $6.8M | Buy |
6,571
+456
| +7% | +$472K | ﹤0.01% | 2791 |
|
|
2023
Q4 | $4.84M | Buy |
6,115
+929
| +18% | +$736K | ﹤0.01% | 2956 |
|
|
2023
Q3 | $2.46M | Sell |
5,186
-210
| -4% | -$99.7K | ﹤0.01% | 3239 |
|
|
2023
Q2 | $3.24M | Buy |
5,396
+122
| +2% | +$73.2K | ﹤0.01% | 3198 |
|
|
2023
Q1 | $3.72M | Sell |
5,274
-217
| -4% | -$153K | ﹤0.01% | 3104 |
|
|
2022
Q4 | $5.63M | Buy |
5,491
+543
| +11% | +$557K | ﹤0.01% | 2990 |
|
|
2022
Q3 | $2.87M | Sell |
4,948
-154
| -3% | -$89.4K | ﹤0.01% | 3303 |
|
|
2022
Q2 | $2.79M | Buy |
5,102
+301
| +6% | +$165K | ﹤0.01% | 3367 |
|
|
2022
Q1 | $3.08M | Buy |
4,801
+395
| +9% | +$253K | ﹤0.01% | 3402 |
|
|
2021
Q4 | $1.82M | Buy |
4,406
+810
| +23% | +$334K | ﹤0.01% | 3666 |
|
|
2021
Q3 | $2.64M | Buy |
+3,596
| New | +$2.64M | ﹤0.01% | 3536 |
|